Nanoparticle-based drug delivery systems to enhance cancer immunotherapy in solid tumors

Immunotherapy has developed rapidly in solid tumors, especially in the areas of blocking inhibitory immune checkpoints and adoptive T-cell transfer for immune regulation. Many patients benefit from immunotherapy. However, the response rate of immunotherapy in the overall population are relatively lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiaxin, Wang, Siyuan, Zhang, Daidi, He, Xin, Wang, Xue, Han, Huiqiong, Qin, Yanru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435760/
https://www.ncbi.nlm.nih.gov/pubmed/37600822
http://dx.doi.org/10.3389/fimmu.2023.1230893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435760/
https://www.ncbi.nlm.nih.gov/pubmed/37600822
http://dx.doi.org/10.3389/fimmu.2023.1230893

Ejemplares similares